Хирургическое лечение рака правой половины ободочной кишки

Хирургическое лечение рака правой половины ободочной кишки

Автор: Невольских А.А., Авдеенко В.А., Резник И.П., Почуев Т.П., Зибиров Р.Ф., Иванов С.А., Каприн А.Д.

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Обзоры

Статья в выпуске: 3 т.23, 2024 года.

Бесплатный доступ

Цель исследования - провести систематический анализ литературы по хирургическому лечению рака правой половины ободочной кишки (РППОК) с применением тотальной мезоколонэктомии (ТМКЭ) и D2/D3-лимфодиссекции. материал и методы. Поиск источников производился в базе данных Pubmed, в обзор включены статьи, опубликованные за последние 10 лет. Включены результаты метаанализов, систематических обзоров, рандомизированных и нерандомизированных клинических исследований, а также клинических рекомендаций.

Рак ободочной кишки, тотальная мезоколонэктомия, рак правой половины ободочной кишки, правосторонняя гемиколэктомия, d3-лимфаденэктомия, оценка качества хирургического вмешательства

Короткий адрес: https://sciup.org/140305919

IDR: 140305919   |   DOI: 10.21294/1814-4861-2024-23-3-133-149

Список литературы Хирургическое лечение рака правой половины ободочной кишки

  • Zlokachestvennye novoobrazovaniya v Rossii v 2021 godu (zabolevaemost' i smertnost'). Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shakhzadovoi. M., 2022. 252 s.
  • Hohenberger W., Weber K., Matzel K., Papadopoulos T., Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis. 2009; 11(4): 354-64; discussion 364-5. https://doi.org/10.1111/j.1463-1318.2008.01735.x.
  • Xu L., Su X., He Z., Zhang C., Lu J., Zhang G., Sun Y., Du X., Chi P., Wang Z., Zhong M., Wu A., Zhu A., Li F., Xu J., Kang L., Suo J., Deng H., Ye Y., Ding K., Xu T., Zhang Z., Zheng M., Xiao Y.; RELARC Study Group. Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial. Lancet Oncol. 2021; 22(3): 391-401. https://doi.org/10.1016/S1470-2045(20)30685-9.
  • Benz S.R., Feder I.S., Vollmer S., Tam Y., Reinacher-Schick A., Denz R., Hohenberger W., Lippert H., Tannapfel A., Stricker I. Complete mesocolic excision for right colonic cancer: prospective multicentre study. Br J Surg. 2022; 110(1): 98-105. https://doi.org/10.1093/bjs/znac379.
  • Tsukamoto S., Ouchi A., Komori K., Shiozawa M., Yasui M., Ohue M., Nogami H., Takii Y., Moritani K., Kanemitsu Y. A multicenter prospective observational study of lymph node metastasis patterns and short-term outcomes of extended lymphadenectomy in right-sided colon cancer. Ann Gastroenterol Surg. 2023; 7(6): 940-8. https://doi.org/10.1002/ags3.12703.
  • Hashiguchi Y., Muro K., Saito Y., Ito Y., Ajioka Y., Hamaguchi T., Hasegawa K., Hotta K., Ishida H., Ishiguro M., Ishihara S., Kanemitsu Y., Kinugasa Y., Murofushi K., Nakajima T.E., Oka S., Tanaka T., Taniguchi H., Tsuji A., Uehara K., Ueno H., Yamanaka T., Yamazaki K., Yoshida M., Yoshino T., Itabashi M., Sakamaki K., Sano K., Shimada Y., Tanaka S., Uetake H., Yamaguchi S., Yamaguchi N., Kobayashi H., Matsuda K., Kotake K., Sugihara K.; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020; 25(1): 1-42. https://doi.org/10.1007/s10147-019-01485-z.
  • Livadaru C., Morarasu S., Frunza T.C., Ghitun F.A., Paiu-Spiridon E.F., Sava F., Terinte C., Ferariu D., Lunca S., Dimofte G.M. Post-operative computed tomography scan - reliable tool for quality assessment of complete mesocolic excision. World J Gastrointest Oncol. 2019; 11(3): 208-26. https://doi.org/10.4251/wjgo.v11.i3.208.
  • Tejedor P., Francis N., Jayne D., Hohenberger W., Khan J.; on behalf the CME Project Working Group. Consensus statements on complete mesocolic excision for right-sided colon cancer-technical steps and training implications. Surg Endosc. 2022; 36(8): 5595-601. https://doi.org/10.1007/s00464-021-08395-0.
  • De Simoni O., Barina A., Sommariva A., Tonello M., Gruppo M., Mattara G., Toniato A., Pilati P., Franzato B. Complete mesocolic excision versus conventional hemicolectomy in patients with right colon cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021; 36(5): 881-92. https://doi.org/10.1007/s00384-020-03797-3.
  • Balciscueta Z., Balciscueta I., Uribe N., Pellino G., Frasson M., García-Granero E., García-Granero Á. D3-lymphadenectomy enhances oncological clearance in patients with right colon cancer. Results of a meta-analysis. Eur J Surg Oncol. 2021; 47(7): 1541-51. https://doi.org/10.1016/j.ejso.2021.02.020.
  • Ferri V., Vicente E., Quijano Y., Duran H., Diaz E., Fabra I., Malave L., Agresott R., Isernia R., Cardinal-Fernandez P., Ruiz P., Nola V., de Nobili G., Ielpo B., Caruso R. Right-side colectomy with complete mesocolic excision vs conventional right-side colectomy in the treatment of colon cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2021; 36(9): 1885-904. https://doi.org/10.1007/s00384-021-03951-5.
  • Anania G., Davies R.J., Bagolini F., Vettoretto N., Randolph J., Cirocchi R., Donini A. Right hemicolectomy with complete mesocolic excision is safe, leads to an increased lymph node yield and to increased survival: results of a systematic review and meta-analysis. Tech Coloproctol. 2021; 25(10): 1099-113. https://doi.org/10.1007/s10151-021-02471-2.
  • De Lange G., Davies J., Toso C., Meurette G., Ris F., Meyer J. Complete mesocolic excision for right hemicolectomy: an updated systematic review and meta-analysis. Tech Coloproctol. 2023; 27(11): 979-93. https://doi.org/10.1007/s10151-023-02853-8.
  • Dai Q., Tu S., Dong Q., Chen B. Laparoscopic Complete Mesocolic Excision Versus Noncomplete Mesocolic Excision: A Systematic Review and Meta-analysis. Surg Laparosc Endosc Percutan Tech. 2020; 31(1): 96-103. https://doi.org/10.1097/SLE.0000000000000845.
  • Ow Z.G.W., Sim W., Nistala K.R.Y., Ng C.H., Koh F.H., Wong N.W., Foo F.J., Tan K.K., Chong C.S. Comparing complete mesocolic excision versus conventional colectomy for colon cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2021; 47(4): 732-7. https://doi.org/10.1016/j.ejso.2020.09.007.
  • Kong J.C., Prabhakaran S., Choy K.T., Larach J.T., Heriot A., Warrier S.K. Oncological reasons for performing a complete mesocolic excision: a systematic review and meta-analysis. ANZ J Surg. 2021; 91(1-2): 124-31. https://doi.org/10.1111/ans.16518.
  • Crane J., Hamed M., Borucki J.P., El-Hadi A., Shaikh I., Stearns A.T. Complete mesocolic excision versus conventional surgery for colon cancer: A systematic review and meta-analysis. Colorectal Dis. 2021; 23(7): 1670-86. https://doi.org/10.1111/codi.15644.
  • Díaz-Vico T., Fernández-Hevia M., Suárez-Sánchez A., GarcíaGutiérrez C., Mihic-Góngora L., Fernández-Martínez D., Álvarez-Pérez J.A., Otero-Díez J.L., Granero-Trancón J.E., García-Flórez L.J. Complete Mesocolic Excision and D3 Lymphadenectomy versus Conventional Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2021; 28(13): 8823-37. https://doi.org/10.1245/s10434-021-10186-9.
  • An M.S., Baik H., Oh S.H., Park Y.H., Seo S.H., Kim K.H., Hong K.H., Bae K.B. Oncological outcomes of complete versus conventional mesocolic excision in laparoscopic right hemicolectomy. ANZ J Surg. 2018; 88(10): 698-702. https://doi.org/10.1111/ans.14493.
  • Yang S.Y., Kim M.J., Kye B.H., Han Y.D., Cho M.S., Jeong S.Y., Cho H.M., Kim H., Kang G.H., Song S.H., Park J.S., Kim J.S., Park S.Y., Kim J., Min B.S. Prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study): study protocol of a multicentre single-arm trial. BMC Cancer. 2020; 20(1): 657. https://doi.org/10.1186/s12885-020-07151-2.
  • Degiuli M., Aguilar A.H.R., Solej M., Azzolina D., Marchiori G., Corcione F., Bracale U., Peltrini R., Di Nuzzo M.M., Baldazzi G., Cassini D., Sica G.S., Pirozzi B., Muratore A., Calabrò M., Jovine E., Lombardi R., Anania G., Chiozza M., Petz W., Pizzini P., Persiani R., Biondi A., Reddavid R. A Randomized Phase III Trial of Complete Mesocolic Excision Compared with Conventional Surgery for Right Colon Cancer: Interim Analysis of a Nationwide Multicenter Study of the Italian Society of Surgical Oncology Colorectal Cancer Network (CoME-in trial). Ann Surg Oncol. 2024; 31(3): 1671-80. https://doi.org/10.1245/s10434-023-14664-0.
  • Sica G.S., Vinci D., Siragusa L., Sensi B., Guida A.M., Bellato V., García-Granero Á., Pellino G. Definition and reporting of lymphadenectomy and complete mesocolic excision for radical right colectomy: a systematic review. Surg Endosc. 2023; 37(2): 846-61. https://doi.org/10.1007/s00464-022-09548-5. Erratum in: Surg Endosc. 2022.
  • Di Buono G., Buscemi S., Cocorullo G., Sorce V., Amato G., Bonventre G., Maienza E., Galia M., Gulotta L., Romano G., Agrusa A. Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-sided Colon Cancer: Short-term Outcomes. A Randomized Clinical Study. Ann Surg. 2021; 274(1): 57-62. https://doi.org/10.1097/SLA.0000000000004557.
  • Kanemitsu Y., Komori K., Kimura K., Kato T. D3 Lymph Node Dissection in Right Hemicolectomy with a No-touch Isolation Technique in Patients With Colon Cancer. Dis Colon Rectum. 2013; 56(7): 815-24. https://doi.org/10.1097/DCR.0b013e3182919093.
  • Kotake K., Mizuguchi T., Moritani K., Wada O., Ozawa H., Oki I., Sugihara K. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis. 2014; 29(7): 847-52. https://doi.org/10.1007/s00384-014-1885-z.
  • Zlokachestvennoe novoobrazovanie obodochnoi kishki [Internet]. Klinicheskie rekomendatsii [cited 2024 Jan 10]. URL: https://cr.minzdrav.gov.ru/schema/396_3.
  • NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Colon Cancer Version 3.2023 [Internet]. [cited 2024 Jan 10]. URL: https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.
  • Argilés G., Tabernero J., Labianca R., Hochhauser D., Salazar R., Iveson T., Laurent-Puig P., Quirke P., Yoshino T., Taieb J., Martinelli E., Arnold D.; ESMO Guidelines Committee. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(10): 1291-305. https://doi.org/10.1016/j.annonc.2020.06.022.
  • Son G.M., Lee I.Y., Lee Y.S., Kye B.H., Cho H.M., Jang J.H., Kim C.N., Lee K.Y., Lee S.H., Kim J.G.; Korean Laparoscopic Colorectal Surgery Study Group. Is Laparoscopic Complete Mesocolic Excision and Central Vascular Ligation Really Necessary for All Patients With RightSided Colon Cancer? Ann Coloproctol. 2021; 37(6): 434-44. https://doi.org/10.3393/ac.2021.00955.0136.
  • Banipal G.S., Stimec B.V., Andersen S.N., Faerden A.E., Edwin B., Baral J., Nesgaard J.M., Benth J.Љ., Ignjatovic D.; R. C. C. study group. Comparing 5-Year Survival Rates Before and After Re-stratification of Stage I-III Right-Sided Colon Cancer Patients by Establishing the Presence/Absence of Occult Tumor Cells and Lymph Node Metastases in the Different Levels of Surgical Dissection. J Gastrointest Surg. 2022; 26(10): 2201-11. https://doi.org/10.1007/s11605-022-05434-6.
  • Brown K.G.M., Ng K.S., Solomon M.J., Chapuis P.H., Koh C.E., Ahmadi N., Austin K.K.S. Complete mesocolic excision for colon cancer: current status and controversies. ANZ J Surg. 2024; 94(3): 309-19. https://doi.org/10.1111/ans.18741.
  • Søndenaa K., Quirke P., Hohenberger W., Sugihara K., Kobayashi H., Kessler H., Brown G., Tudyka V., D’Hoore A., Kennedy R.H., West N.P., Kim S.H., Heald R., Storli K.E., Nesbakken A., Moran B. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery: proceedings of a consensus conference. Int J Colorectal Dis. 2014; 29(4): 419-28. https://doi.org/10.1007/s00384-013-1818-2.
  • Kaye T.L., West N.P., Jayne D.G., Tolan D.J. CT assessment of right colonic arterial anatomy pre and post cancer resection - a potential marker for quality and extent of surgery? Acta Radiol. 2016; 57(4): 394-400. https://doi.org/10.1177/0284185115583033.
  • Ankersmit M., Bonjer H.J., Hannink G., Schoonmade L.J., van der Pas M.H.G.M., Meijerink W.J.H.J. Near-infrared fluorescence imaging for sentinel lymph node identification in colon cancer: a prospective singlecenter study and systematic review with meta-analysis. Tech Coloproctol. 2019; 23(12): 1113-26. https://doi.org/10.1007/s10151-019-02107-6.
  • Liu J., Su Y., Liu X., Zhuang J., Yang Y., Guan G. Clinical analysis of metastatic characteristics of infrapyloric lymph nodes (No.206) and terminal ileum lymph nodes in patients with right colon cancer. World J Surg Oncol. 2021; 19(1): 310. https://doi.org/10.1186/s12957-021-02414-z.
  • Yalikun A., Cai Z., Hong H.J., Dai K., Li S., Kwan W., Ma J., Feng B., Lu A., Zheng M., Zang L. Infrapyloric (No. 206) and greater curvature (No. 204) lymph node metastasis in adenocarcinoma located in the right half of the transverse colon (InCLART Study): protocol for a multicentre prospective observational study. BMJ Open. 2023; 13(2). https://doi.org/10.1136/bmjopen-2022-066981.
  • Piozzi G.N., Rusli S.M., Baek S.J., Kwak J.M., Kim J., Kim S.H. Infrapyloric and gastroepiploic node dissection for hepatic flexure and transverse colon cancer: A systematic review. Eur J Surg Oncol. 2022; 48(4): 718-26. https://doi.org/10.1016/j.ejso.2021.12.005.
  • Yoon S., Ji W.B., Kim J.S., Hong K.D., Um J.W., Min B.W., Lee S.I., Kang S., Ju Y., Kim J., Kwak J.M., Baek S.J. Long-term oncologic outcome of D3 lymph node dissection for clinical stage 2/3 right-sided colon cancer. Int J Colorectal Dis. 2023; 38(1): 42. https://doi.org/10.1007/s00384-023-04310-2.
  • Degiuli M., Solej M., Resendiz Aguilar H.A., Marchiori G., Reddavid R. Complete mesocolic excision in comparison with conventional surgery for right colon cancer: a nationwide multicenter study of the Italian Society of Surgical Oncology colorectal cancer network (CoME-in trial). Study protocol for a randomized controlled trial. Jpn J Clin Oncol. 2022; 52(10): 1232-41. https://doi.org/10.1093/jjco/hyac116.
  • Lu J.Y., Xu L., Xue H.D., Zhou W.X., Xu T., Qiu H.Z., Wu B., Lin G.L., Xiao Y. The Radical Extent of lymphadenectomy - D2 dissection versus complete mesocolic excision of LAparoscopic Right Colectomy for rightsided colon cancer (RELARC) trial: study protocol for a randomized controlled trial. Trials. 2016; 17(1): 582. https://doi.org/10.1186/s13063-016-1710-9.
  • Toyota S., Ohta H., Anazawa S. Rationale for extent of lymph node dissection for right colon cancer. Dis Colon Rectum. 1995; 38(7): 705-11. https://doi.org/10.1007/BF02048026.
  • Wang X., Huang S., Lu X., Huang Y., Chi P. Incidence of and Risk Factors for Gastroepiploic Lymph Node Involvement in Patients with Cancer of the Transverse Colon Including the Hepatic Flexure. World J Surg. 2021; 45(5): 1514-25. https://doi.org/10.1007/s00268-020-05933-0.
  • Spasojevic M., Stimec B.V., Dyrbekk A.P., Tepavcevic Z., Edwin B., Bakka A., Ignjatovic D. Lymph node distribution in the d3 area of the right mesocolon: implications for an anatomically correct cancer resection. A postmortem study. Dis Colon Rectum. 2013; 56(12): 1381-7. https://doi.org/10.1097/01.dcr.0000436279.18577.d3.
  • Andersen B.T., Stimec B.V., Kazaryan A.M., Rancinger P., Edwin B., Ignjatovic D. Re-interpreting mesenteric vascular anatomy on 3D virtual and/or physical models, part II: anatomy of relevance to surgeons operating splenic flexure cancer. Surg Endosc. 2022; 36(12): 9136-45. https://doi.org/10.1007/s00464-022-09394-5.
  • Thorsen Y., Stimec B.V., Lindstrom J.C., Nesgaard J.M., Oresland T., Ignjatovic D. Bowel Motility After Injury to the Superior Mesenteric Plexus During D3 Extended Mesenterectomy. J Surg Res. 2019; 239: 115-24. https://doi.org/10.1016/j.jss.2019.02.004.
  • Mazzarella G., Muttillo E.M., Picardi B., Rossi S., Muttillo I.A. Complete mesocolic excision and D3 lymphadenectomy with central vascular ligation in right-sided colon cancer: a systematic review of postoperative outcomes, tumor recurrence and overall survival. Surg Endosc. 2021; 35(9): 4945-55. https://doi.org/10.1007/s00464-021-08529-4.
  • Gaupset R., Nesgaard J.M., Kazaryan A.M., Stimec B.V., Edwin B., Ignjatovic D. Introducing Anatomically Correct CT-Guided Laparoscopic Right Colectomy with D3 Anterior Posterior Extended Mesenterectomy: Initial Experience and Technical Pitfalls. J Laparoendosc Adv Surg Tech A. 2018; 28(10): 1174-82. https://doi.org/10.1089/lap.2018.0059.
  • Nesgaar J.M., Stimec B.V., Bakka A.O., Edwin B., Bergamaschi R., Ignjatovic D. Right Colectomy with Extended D3 Mesenterectomy: Anterior and Posterior to the Mesenteric Vessels. Surg Technol Int. 2019; 35: 138-42.
  • Watanabe J., Ota M., Suwa Y., Ishibe A., Masui H., Nagahori K. Evaluation of lymph flow patterns in splenic flexural colon cancers using laparoscopic real-time indocyanine green fluorescence imaging. Int J Colorectal Dis. 2017; 32(2): 201-7. https://doi.org/10.1007/s00384-016-2669-4.
  • Yi X., Li H., Lu X., Wan J., Diao D. “Caudal-to-cranial” plus “artery first” technique with beyond D3 lymph node dissection on the right midline of the superior mesenteric artery for the treatment of right colon cancer: is it more in line with the principle of oncology? Surg Endosc. 2020; 34(9): 4089-100. https://doi.org/10.1007/s00464-019-07171-5.
  • Banipal G.S., Stimec B.V., Andersen S.N., Edwin B., Nesgaard J.M., Šaltytė Benth J., Ignjatovic D.; RCC study group. Are Metastatic Central Lymph Nodes (D3 volume) in right-sided Colon Cancer a Sign of Systemic Disease? A sub-group Analysis of an Ongoing Multicenter Trial. Ann Surg. 2024; 279(4): 648-56. https://doi.org/10.1097/SLA.0000000000006099.
  • Sato Y., Satoyoshi T., Okita K., Kyuno D., Hamabe A., Okuya K., Nishidate T., Akizuki E., Ishii M., Yamano H.O., Sugita S., Nakase H., Hasegawa T., Takemasa I. Snapshots of lymphatic pathways in colorectal cancer surgery using near-infrared fluorescence, in vivo and ex vivo. Eur J Surg Oncol. 2021; 47(12): 3130-6. https://doi.org/10.1016/j.ejso.2021.07.025.
  • Garcia-Granero A., Pellino G., Giner F., Frasson M., Grifo Albalat I., Sánchez-Guillén L., Valverde-Navarro A.A., Garcia-Granero E. A Proposal for Novel Standards of Histopathology Reporting for D3 Lymphadenectomy in Right Colon Cancer: The Mesocolic Sail and Superior Right Colic Vein Landmarks. Dis Colon Rectum. 2020; 63(4): 450-60. https://doi.org/10.1097/DCR.0000000000001589.
  • West N.P., Morris E.J., Rotimi O., Cairns A., Finan P.J., Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008; 9(9): 857-65. https://doi.org/10.1016/S1470-2045(08)70181-5.
  • Benz S., Tannapfel A., Tam Y., Grünenwald A., Vollmer S., Stricker I. Proposal of a new classification system for complete mesocolic excison in right-sided colon cancer. Tech Coloproctol. 2019; 23(3): 251-7. https://doi.org/10.1007/s10151-019-01949-4.
  • Ahn H.M., Son G.M., Lee I.Y., Shin D.H., Kim T.K., Park S.B., Kim H.W. Optimal ICG dosage of preoperative colonoscopic tattooing for fluorescence-guided laparoscopic colorectal surgery. Surg Endosc. 2022; 36(2): 1152-63. https://doi.org/10.1007/s00464-021-08382-5.
  • Ribero D., Mento F., Sega V., Lo Conte D., Mellano A., Spinoglio G. ICG-Guided Lymphadenectomy during Surgery for Colon and Rectal Cancer-Interim Analysis of the GREENLIGHT Trial. Biomedicines. 2022; 10(3): 541. https://doi.org/10.3390/biomedicines10030541.
  • Ho M.F., Futaba K., Mak T.W.C., Ng S.S.M. Personalized laparoscopic resection of colon cancer with the use of indocyanine green lymph node mapping: Technical and clinical outcomes. Asian J Endosc Surg. 2022; 15(3): 563-8. https://doi.org/10.1111/ases.13050.
  • Park J.H., Moon H.S., Kwon I.S., Yun G.Y., Lee S.H., Park D.H., Kim J.S., Kang S.H., Lee E.S., Kim S.H., Sung J.K., Lee B.S., Jeong H.Y. Usefulness of colonic tattooing using indocyanine green in patients with colorectal tumors. World J Clin Cases. 2018; 6(13): 632-40. https://doi.org/10.12998/wjcc.v6.i13.632.
  • Ushijima H., Kawamura J., Ueda K., Yane Y., Yoshioka Y., Daito K., Tokoro T., Hida J.I., Okuno K. Visualization of lymphatic flow in laparoscopic colon cancer surgery using indocyanine green fluorescence imaging. Sci Rep. 2020; 10(1). https://doi.org/10.1038/s41598-020-71215-3.
  • Nishigori N., Koyama F., Nakagawa T., Nakamura S., Ueda T., Inoue T., Kawasaki K., Obara S., Nakamoto T., Fujii H., Nakajima Y. Visualization of Lymph/Blood Flow in Laparoscopic Colorectal Cancer Surgery by ICG Fluorescence Imaging (Lap-IGFI). Ann Surg Oncol. 2016; 23s2: 266-74. https://doi.org/10.1245/s10434-015-4509-0.
  • Kakizoe M., Watanabe J., Suwa Y., Nakagawa K., Suwa H., Ozawa M., Ishibe A., Masui H., Nagahori K. The histopathological evaluation based on the indocyanine green fluorescence imaging of regional lymph node metastasis of splenic flexural colon cancer by near-infrared observation. Int J Colorectal Dis. 2021; 36(4): 717-23. https://doi.org/10.1007/s00384-020-03798-2.
  • Petz W., Bertani E., Borin S., Fiori G., Ribero D., Spinoglio G. Fluorescence-guided D3 lymphadenectomy in robotic right colectomy with complete mesocolic excision. Int J Med Robot. 2021; 17(3). https://doi.org/10.1002/rcs.2217.
  • ICG-fluorestsentnaya navigatsiya v sovremennoi khirurgicheskoi praktike. Pod red. A.D. Kaprina, S.A. Ivanova. Obninsk-Moskva, 2023. 136 s.
Еще
Статья обзорная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp